Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL) after Frontline Therapy with Hyper-CVAD Regimens.

被引：0
|
作者：
Thomas, Deborah A.
O'Brien, Susan [1 ]
Rytting, Michael
Faderl, Stefan
Cortes, Jorge
Wierda, William G.
Ravandi, Farhad [1 ]
Kantarjian, Hagop M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：674 / 674
页数：1
相关论文
共 50 条
  • [41] Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia
    Thomas, DA
    Cortes, J
    O'Brien, S
    Pierce, S
    Faderl, S
    Albitar, M
    Hagemeister, FB
    Cabanillas, FF
    Murphy, S
    Keating, MJ
    Kantarjian, H
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) : 2461 - 2470
  • [42] Comparison of Two Pediatric-Inspired Regimens to Hyper-CVAD in Hispanic Adolescents and Young Adults With Acute Lymphoblastic Leukemia
    Almanza-Huante, Emmanuel
    Espinosa-Bautista, Karla
    Rangel-Patino, Juan
    Demichelis-Gomez, Roberta
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 (01): : 55 - +
  • [43] Intensification of hyper-CVAD with L-asparaginase, vincristine, and dexamethasone ("Augmented Hyper-CVAD") has activity in adult patients with relapsed/refractory acute lymphoblastic leukemia (ALL).
    Fader, Stefan
    Thomas, Deborah A.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Beran, Miloslav
    Rytting, Michael
    Koller, Charles A.
    Verstovsek, Srdan
    Borthakur, Gautam
    Andreeff, Michael
    Kornblau, Steve
    O'Brien, Susan
    Vu, Khanh
    Kwari, Monica
    Bretz, Jennie
    Kantarjian, Hagop M.
    BLOOD, 2007, 110 (11) : 149B - 149B
  • [44] A Comprehensive Cancer Center Experience with Hyper-CVAD Plus Ponatinib As Frontline Therapy for Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Othman, Tamer
    Moskoff, Benjamin
    Tenold, Matthew
    Azenkot, Tali
    Krackeler, Margaret
    Fisch, Samantha C.
    Potter, Laura A.
    Kaesberg, Paul R.
    Welborn, Jeanna
    Wun, Ted
    Esteghamat, Naseem
    Hoeg, Rasmus T.
    Rosenberg, Aaron S.
    Abedi, Mehrdad
    Tuscano, Joseph
    Jonas, Brian A.
    BLOOD, 2021, 138
  • [45] Therapy related acute. myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyper-CVAD regimen
    Verma, Dushyant
    Thomas, Deborah
    O'Brien, Susan
    Faderl, Stefan
    Koller, Charles
    Pierce, Sherry
    Estey, Elihu
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Kantarjian, Hagop
    Ravandi, Farhad
    BLOOD, 2007, 110 (11) : 833A - 833A
  • [46] Treatment of adult acute lymphoblastic leukemia (ALL) with the hyper-CVAD regimen - Preliminary analysis from a single center
    Marinakis, T
    Zomas, A
    Michalis, E
    Gortzolidis, G
    Galanopoulos, A
    Grigoraki, V
    Paterakis, G
    Leivada, A
    Griva, E
    Papadimitriou, E
    Skandalis, A
    BLOOD, 2002, 100 (11) : 272B - 272B
  • [47] A Phase II Study of the Hyper-CVAD Regimen in Sequential Combination with Blinatumomab As Frontline Therapy for Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL)
    Richard-Carpentier, Guillaume
    Kantarjian, Hagop M.
    Short, Nicholas J.
    Ravandi, Farhad
    Ferrajoli, Alessandra
    Schroeder, Heather M.
    Khouri, Maria
    Garcia-Manero, Guillermo
    Bravo, Guillermo Montalban
    Cortes, Jorge E.
    Jain, Nitin
    Konopleva, Marina Y.
    Takahashi, Koichi
    Sasaki, Koji
    Garris, Rebecca E.
    Jabbour, Elias J.
    BLOOD, 2018, 132
  • [48] Hyper-CVAD Plus Ponatinib as Frontline Therapy in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL): Updated Results of a Phase II Trial
    Maiti, Abhishek
    Kantarjian, Hagop
    Ravandi, Farhad
    Short, Nicholas
    Daver, Naval
    Pemmaraju, Naveen
    Thomas, Deborah
    Yilmaz, Musa
    Kadia, Tapan
    Sasaki, Koji
    Garris, Rebecca
    Garcia-Manero, Guillermo
    DiNardo, Courtney
    Konopleva, Marina
    Estrov, Zeev
    Jain, Nitin
    Weirda, William
    Jeanis, Vicky
    Cortes, Jorge
    O'Brien, Susan
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S257 - S258
  • [49] Phase II Study of the Frontline Hyper-CVAD in Combination with Ofatumumab for Adult Patients (pts) with CD-20 Positive Acute Lymphoblastic Leukemia (ALL)
    Sasaki, Koji
    Koller, Paul B.
    Kantarjian, Hagop M.
    Thomas, Deborah A.
    Khouri, Maria R.
    Garcia-Manero, Guillermo
    Garris, Rebecca
    Cortes, Jorge E.
    Schroeder, Heather
    Chahoud, Jad
    Kadia, Tapan
    Ravandi, Farhad
    Verstovsek, Srdan
    Daver, Naval
    Jain, Nitin
    Konopleva, Marina
    O'Brien, Susan
    Jabbour, Elias
    BLOOD, 2015, 126 (23)
  • [50] Frontline Hyper-CVAD with Ponatinib for Patients (pts) with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia: Results of a Phase II Study
    Sasaki, Koji
    O'Brien, Susan
    Ravandi, Farhad
    Thomas, Deborah A.
    Moore, Haim G.
    Cortes, Jorge E.
    Pemmaraju, Naveen
    Yilmaz, Musa
    Kadia, Tapan
    Garris, Rebecca
    Garcia-Manero, Guillermo
    Jeanis, Twilla Victoria
    Chahoud, Jad
    Borthakur, Gautam
    Wierda, William
    Ferrajoli, Alessandra
    Kantarjian, Hagop M.
    Jabbour, Elias
    BLOOD, 2015, 126 (23)
12345